Related Experiment Video
Updated: Feb 19, 2026

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Global trends of pandemic-prone and epidemic-prone disease outbreaks in 2024
Juan Armando Torres Munguía1, Inmaculada Martínez-Zarzoso2,3
1Department of Economics, University of Goettingen, Göttingen, NDS, Germany.
Abstract:
During 2024, the number of pandemic-prone and epidemic-prone disease outbreaks worldwide was estimated at 301. The data highlight a shift in disease outbreak patterns, with a decline in the number of countries reporting public health events of concern linked to COVID-19 and a rise in those reporting outbreaks of viral diseases transmitted by vectors.About 90% of the outbreaks in 2024 were associated with COVID-19, dengue, yellow fever, Oropouche virus disease and influenza (linked to identified zoonotic or pandemic influenza virus). Although disease outbreaks can affect any country anywhere, they tend to disproportionately occur in countries facing many other socio-economic development, climatic and humanitarian challenges. In this regard, sub-Saharan Africa and the subregion of Latin America and the Caribbean-home to just 23.3% of the world's population-reported the highest number of disease outbreaks in 2024 with about 57% of the total. Particularly, the sub-Saharan Africa region has been the site of nearly 32% of recorded outbreaks since 1996. Future research should include efforts to improve the quality and availability of disease outbreaks data-particularly in the most exposed or vulnerable regions-and to promote the scientific use of such information for foresight purposes and for forecasting future health events of concern to support anticipatory action.
Insights
Global disease outbreaks in 2024 show a shift from COVID-19 to vector-borne viral diseases. Sub-Saharan Africa and Latin America face disproportionate outbreaks, highlighting regional vulnerabilities.
Area of Science:
- Epidemiology
- Global Health Security
- Public Health Surveillance
Background:
- In 2024, 301 pandemic- and epidemic-prone disease outbreaks occurred globally.
- A notable shift in disease patterns was observed, with fewer COVID-19-related events and an increase in vector-borne viral diseases.
Purpose of the Study:
- To analyze global disease outbreak trends in 2024.
- To identify geographical disparities in outbreak occurrences.
- To highlight the need for improved data and forecasting for public health events.
Main Methods:
- Analysis of reported disease outbreaks worldwide for 2024.
- Comparison of outbreak data with previous years and population distribution.
- Identification of key diseases and affected regions.
Main Results:
- Approximately 90% of 2024 outbreaks involved COVID-19, dengue, yellow fever, Oropouche virus disease, and influenza.
- Sub-Saharan Africa and Latin America/Caribbean reported 57% of global outbreaks, despite lower populations.
- Sub-Saharan Africa has consistently reported a high proportion of outbreaks since 1996.
Conclusions:
- Disease outbreaks are increasingly shifting towards vector-borne viral diseases.
- Vulnerable regions, particularly in sub-Saharan Africa, bear a disproportionate burden of outbreaks.
- Enhanced data quality, availability, and scientific utilization are crucial for future disease outbreak prediction and anticipatory action.
Related Concept Videos
Steps in Outbreak Investigation
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Principles of Disease Surveillance
Microorganisms in Medicine and Therapeutics

